Digital pharma company in Europe for sale

Company for sale

• Size: medium
• Location: Europe (country will be specified in later stages)
• Sales: > 4 million EUR
• Valuation: > 10 million EUR
• Established: Less than 5 years ago
• Reason for sale: The owners are selling the company due to their desire to boost the company’s growth which can be achieved by gaining financial strength
• #CFIE PHS058

Overview of this digital pharma firm for sale

The owners of an innovative digital company operating in the pharma industry have decided to look for potential buyers for their company or venture investors able to invest money into a prospective project. The company has already been funded by an investor, however, for a full rollout of their product, they would need additional capital from investors.

Profile (strategy) of this pharma IT company for sale

This company for sale is a small company specializing in digital marketing in the healthcare and pharmaceutical industries. Currently, the company targets European markets and South America. The company is targeting mainly generic and original pharma companies.

The company’s customers include the following:

• Healthcare institutions
• Pharma companies
• Patients
• Doctors
• Medical professionals

The company is highly innovative and strives to bring digitalization into the pharma industry. The company wants to be the leader of this trend, and it already has helped many companies with digitalization.

The company has an experienced management team, with 60+ years of cumulative experience in the healthcare and pharmaceutical industries. This team would stay in the company after the entry of the investor.

Activities and products of this IT pharma company for sale

The product of the company is a software solution. It is a digital marketing tool with multiple functionalities. The product has already been implemented by several clients, with high customer satisfaction and success stories. The main future of the company’s product is the capabilities for the institutional healthcare market and for communicating directly with professionals in the healthcare sector. The full functionality of the software will be disclosed to seriously interested parties upon signing an NDA.

The company is only in its startup phase, however, it has commercialized its product already and generated revenues. The project plan includes a lucrative IRR for investors of over 75%.

For the fast roll-out of the company’s product, the owners will need a capital injection of approx. 5-10 million euros. After rolling out, the project will demonstrate exponential growth in revenue and profits. In 5 years, the cash flow plan is projecting revenues of over 70 million euros and an EBITDA of 50 million euros.

Highlights of the pharma company for sale

• The company has a very experienced, seasoned management
• The company is in the startup phase, however, it is already generating revenues
• The investor would gain a company with potential exponential growth in clients, revenue, and EBITDA

More information on this digital pharma company in Europe for sale

Please get in touch if you are interested in learning more about this digital pharma company in Europe for sale. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.